News about Market

Symbiosis Expands QC Capabilities with New Stability Chamber to Support Global Drug Supply

Symbiosis enhances its quality control lab with a new stability chamber, enabling comprehensive climate-based testing for global distribution of injectable drug products.

Market | 06/04/2026 | By News Bureau |  239

Syneron Bio Raises USD 150 Million in Series B Funding

Syneron Bio raises USD 150 million in Series B to advance its Synova macrocyclic peptide platform and accelerate pipeline development towards clinical stages.

Market | 06/04/2026 | By News Bureau |  170

TechBio Startup Generare Raises 20 Million Euros to Unlock Novel Drug Discovery Data

Generare, a techbio company focused on generating novel molecular data for drug discovery, has raised 20 million euros in a Series A funding round co-led by Alven and Daphni, with participation from existing investors including Galion.exe, Teampact Ventures and VIVES Partners.

Market | 04/04/2026 | By Darshana |  268

Aspect Biosystems Secures USD 280 Million Canada Partnership for Bioengineered Cell Therapies

Aspect Biosystems secures USD 280 Million partnership with Canada to advance bioengineered cell therapies, accelerating clinical development and expanding biomanufacturing capabilities.

Market | 04/04/2026 | By News Bureau |  127

MHRA Approves Bayer's Sevabertinib for HER2-Mutated Advanced Lung Cancer

Sevabertinib, a targeted therapy for HER2-mutated lung cancer, has been approved by the UK regulator to expand treatment options for advanced-stage patients.

Market | 04/04/2026 | By News Bureau |  201

Lupin Expands Specialty Care Business with VISUfarma Buyout

Lupin Limited has announced the completion of its acquisition of VISUfarma B.V. from GHO Capital Partners LLP, marking a significant step in strengthening its specialty care portfolio and expanding its footprint in Europe.

Market | 02/04/2026 | By Darshana |  111

European Commission Approves Needle-Free Adrenaline Nasal Spray for Children with Severe Allergies

ALK’s EURneffy 1 mg expands access to needle-free emergency treatment for anaphylaxis in children aged 4 and above across the EU.

Market | 02/04/2026 | By News Bureau |  140

Gilead Extends Tender Offer to Acquire Arcellx

Gilead extends tender offer to acquire Arcellx until April 24, 2026, providing additional time for shareholders to participate in the proposed acquisition.

Market | 02/04/2026 | By News Bureau |  219

GHIT Fund and TSRI Sign MoU to Boost Global Infectious Disease R&D Collaboration

The partnership aims to co-fund research on malaria, tuberculosis, and neglected tropical diseases while strengthening innovation ecosystems and capacity building across Thailand and Japan.

Market | 01/04/2026 | By News Bureau |  143

Semarion Raises USD 3.8 Million to Scale Cell Assay Technology and Accelerate Pharma Adoption

Semarion raises USD 3.8 million to expand manufacturing and scale its SemaCyte microcarrier platform for pharmaceutical use.

Market | 01/04/2026 | By News Bureau |  187